← All trials
NCT05811000
Phase 2/Phase 3Interventional
Trials that are a combination of phases 2 and 3.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Nov 27, 2020
- Primary completion
- Feb 24, 2021
- Completion date
- Aug 13, 2024
- First posted
- Apr 13, 2023
- Last posted
- Apr 18, 2023
- Enrollment
- 312
- Arms / groups
- 4 / —
- Source
- AACT · ctgov ingestion
Sponsors
- MediforumLead sponsor
- LSK Global Pharma Services Co. Ltd.Collaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.